Wednesday, March 20 - We are currently experiencing technical issues with our phone lines. We are working to resolve the issue.
Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.
Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.